| Excerpt | Reference |
|---|
| "The obstructive sleep apnea syndrome is characterized by the occurrence of cyclic snoring and frequent apneic episodes during sleep, with consequent hypoxia and hypercapnia." | ( Chase, MH; Fung, SJ; Morales, FR; Xi, M; Yamuy, J, 1999) |
| "Obstructive sleep apnea syndrome is characterized by periodic apnea/hypopnea, which is often associated with severe hypoxemia." | ( Nishimura, M; Tsujino, I, 2000) |
| "Obstructive sleep apnea syndrome is common in middle-aged men and may be associated with an increased risk of cardiovascular disease." | ( Chin, K; Mishima, M; Miyasaka, M; Nakamura, T; Ohi, M; Shimizu, K, 2000) |
| "Obstructive sleep apnea is a disorder characterized by recurrent collapse of the upper airway that is likely due to decline of pharyngeal motoneuron activity during sleep." | ( Bocchiaro, CM; Chamberlin, NL; Feldman, JL; Greene, RW, 2002) |
| "Obstructive sleep apnea is more related to BP variability than BP." | ( Bao, X; Dimsdale, JE; Loredo, JS; Nelesen, RA; Ziegler, MG, 2002) |
| "Obstructive sleep apnea is associated with significant daytime sleepiness, reduced quality of life, insulin resistance, motor vehicle crashes, vascular morbidity and mortality." | ( Strollo, PJ, 2003) |
| "Obstructive sleep apnea is a common disorder that is often unrecognized and underappreciated." | ( Phillips, BG; Somers, VK, 2003) |
| "The obstructive sleep apnea syndrome is typically associated with conditions known to increase insulin resistance as hypertension, obesity, and diabetes." | ( Ficker, JH; Fuchs, FS; Hahn, EG; Harsch, IA; Jahreiss, H; Konturek, PC; Lohmann, T; Radespiel-Tröger, M; Schahin, SP; Weintz, O; Wiest, GH, 2004) |
| "Obstructive sleep apnea is associated with daytime sleepiness and fatigue, likely due to fragmented sleep from recurrent arousals." | ( Parish, JM; Somers, VK, 2004) |
| "Obstructive sleep apnea is characterized by prolonged, generally partial, upper airways obstruction associated with hypoxemia and/or hypercapnia." | ( Alonso Alvarez, ML; Castrodeza Sanz, J; Cordero Guevara, J; de Abajo Cucurull, C; González Martinez, M; Terán Santos, J, 2004) |
| "OSAHS is one of the risk factors for CHD." | ( Li, SF; Li, YM; Ma, ZY; Shi, XN; Tan, H; Zhang, J; Zheng, XW, 2006) |
| "We conclude that obstructive sleep apnea syndrome is associated with changes in levels of adhesion molecules, and that this could be the result of obstructive sleep apnea syndrome-induced hypoxia." | ( Gude-Sampedro, F; Ricoy-Galbaldon, J; Riveiro-Riveiro, A; Zamarrón-Sanz, C, 2006) |
| "Obstructive sleep apnea syndrome is associated with bronchial inflammation." | ( Devouassoux, G; Fior-Gozlan, M; Henry, M; Lévy, P; Pépin, JL; Pin, I; Rossini, E; Seigneurin, D, 2007) |
| "Obstructive sleep apnea is associated with increased risk for cardiovascular diseases." | ( Park, AM; Suzuki, YJ, 2007) |
| "Obstructive sleep apnea is common in obese people." | ( Fujimoto, K; Hanaoka, M; Kubo, K; Ota, M; Urushihata, K; Yu, X, 2008) |
| "Obstructive sleep apnea is associated with changes in QT interval variability during sleep." | ( Abbott, D; Baumert, M; Catcheside, P; McEvoy, RD; Nalivaiko, E; Sanders, P; Smith, J, 2008) |
| "Patients with obstructive sleep apnea are at risk for perioperative morbidity." | ( Gali, B; Gay, PC; Plevak, DJ; Schroeder, DR; Whalen, FX, 2009) |
| "Obstructive sleep apnea is a common disorder associated with upper airway muscle dysfunction." | ( Bradford, A; Jones, JF; O'Halloran, KD; Skelly, JR, 2010) |
| "Obstructive sleep apnea is primarily characterized by hypoxemia due to frequent apneic episodes and fragmentation of sleep due to the brief arousals that terminate the apneic episodes." | ( Connolly, NP; McCarley, RW; McCoy, JG; McKenna, JT; Strecker, RE; Ward, CP, 2009) |
| "OSAHS is strongly associated with obesity, but there are many other clinical risk factors, such as the dentofacial characteristics of hard and soft tissues, hyoid bone position, neck circumference, upper airway spaces and nasal respiration." | ( Campos, JM; Ferraz, EM; Laureano Filho, JR; Maciel Santos, ME, 2011) |
| "OSAHS is a potential risk factor on the cardiovascular diseases and the metabolism disorders." | ( Ge, R; He, T; Jia, C; Liu, W; Mei, X; Zhang, Q, 2010) |
| "Obstructive sleep apnea is a frequent medical condition consisting in repetitive sleep-related episodes of upper airways obstruction and concurrent events of arterial blood hypoxia." | ( Bustamante, R; Castañeda, J; Conde, SV; Gonzalez, C; Gonzalez-Martín, MC; Obeso, A; Olea, E; Perez-Vizcaino, F; Vega-Agapito, MV, 2011) |
| "Obstructive sleep apnea is associated with decreased R-R interval length and overall R-R interval variability in the electrocardiogram along with increased morning brain natriuretic peptide (BNP) blood levels." | ( Alexopoulos, EI; Chaidas, K; Gourgoulianis, K; Kaditis, AG; Malakasioti, G; Varlami, V, 2011) |
| "Obstructive sleep apnea is associated with increased cardiovascular morbidity and mortality." | ( Butt, M; Dwivedi, G; Khair, OA; Lip, GY; Shantsila, A; Shantsila, E, 2011) |
| "OSAHS is associated with a high frequency of impaired glucose metabolism." | ( Guo, XH; Meng, WL, 2011) |
| "Obstructive sleep apnea is associated with sympathovagal disbalance, AF, and postapneic BP rises." | ( Böhm, M; Linz, D; Mahfoud, F; Neuberger, HR; Schotten, U; Ukena, C; Wirth, K, 2012) |
| "Obstructive sleep apnea is a common disease, affecting 16% of the working age population." | ( Ji, ES; Li, X; Liu, Y; Weiss, JW, 2012) |
| "OSAHS is a common disease with many factors related to the etiology." | ( Chen, D; Hu, X; Huang, J; Lai, H; Li, C; Lin, S; Liu, J; Tan, J; Wang, D; Yang, J; Zheng, L; Zhu, H, 2013) |
| "The obstructive sleep apnea syndrome is common and its prevalence is expected to increase with the current obesity epidemic." | ( Marcus, CL; Tapia, IE, 2013) |
| "Obstructive sleep apnea is characterized by repetitive collapses of the upper airway, negative thoracic pressure periods, and intermittent hypoxia, stimulating the autonomic nervous system." | ( Böhm, M; Ewen, S; Hohl, M; Linz, D; Maack, C; Mahfoud, F; Nickel, A; Schotten, U; Wagner, M; Wirth, K, 2013) |
| "Obstructive sleep apnea is associated with insulin resistance, glucose intolerance, and type 2 diabetes mellitus." | ( Drager, LF; McHugh, H; Polak, J; Polotsky, VY; Punjabi, NM; Shimoda, LA; Undem, C, 2013) |
| "Obstructive sleep apnea is associated with considerable health risks." | ( Cornelius, J; de Vries, N; Feldman, N; Froymovich, O; Gillespie, MB; Goetting, MG; Hanson, RD; Knaack, L; Maurer, JT; Padhya, TA; Soose, RJ; Steward, DL; Strohl, KP; Strollo, PJ; Van de Heyning, PH; Vanderveken, OM; Woodson, BT, 2014) |
| "Obstructive sleep apnea is prevalent among people with asthma, but underlying mechanisms remain unknown." | ( Bioty, N; Chinchilli, VM; Eckert, DJ; Fedie, JE; Gong, Y; Hind, J; Huard, T; Israel, E; Kunselman, SJ; Loredo, J; Malhotra, A; Miller, B; Peterson, E; Ramsdell, J; Reeder, S; Robbins, J; Sexton, A; Soler, X; Sorkness, CA; Teodorescu, M; Xie, A, 2014) |
| "Obstructive sleep apnea syndrome is characterized by repetitive obstruction of the upper airways, and it is a risk factor for cardiovascular diseases." | ( Öğünç, AV; Okur, HK; Öztürk, L; Pelin, Z; Yüksel, M, 2014) |
| "Obstructive sleep apnea syndrome is associated with airway inflammation." | ( JalilMirmohammadi, S; Mehrparvar, AH; Safaei, S; Samimi, E; Torab Jahromi, M, 2014) |
| "Obstructive sleep apnea is common in patients admitted to the ICU." | ( Afessa, B; Bolona, E; Hahn, PY, 2015) |
| "Obstructive Sleep Apnea is a chronic sleep disorder affecting a large number of the global population." | ( Spyropoulos, B; Tzavaras, A, 2014) |
| "Obstructive sleep apnea is a common disorder associated with aging and obesity." | ( Fagundes, M; Fiori, CZ; Kaminski, RS; Marroni, NP; Martinez, D; Martins, EF; Montanari, CC; Rosa, DP, 2015) |
| "Obstructive sleep apnea syndrome is associated with enhanced platelets aggregations, which may predispose the cardiovascular sequels." | ( Alkhiary, W; Arram, EO; El-Saddik, AM; Morsy, NE; Yousef, AM, 2017) |
| "Obstructive sleep apnea is a well-known clinical manifestation of Prader-Willi syndrome." | ( Bussi, M; Di Candia, S; Giordano, L; Palonta, F; Teggi, R; Toma, S; Zucconi, M, 2015) |
| "Obstructive sleep apnea is a state-dependent disease." | ( Eckert, DJ; Edwards, BA; Marques, M; Sands, SA; Taranto-Montemurro, L; Wellman, A; White, DP, 2016) |
| "Obstructive sleep apnea is associated with inflammation and oxidative stress in lung tissues and can lead to metabolic abnormalities." | ( Hu, K; Kang, J; Li, Y; Lu, W; Tang, S; Xu, L; Yu, S; Zhou, X, 2016) |
| "Obstructive sleep apnea is diagnosed and graded by conventional thresholds of apneas and hypopneas per hour of sleep, and treatment is usually initiated in the presence of symptoms." | ( Haile, SR; Kohler, M; Rossi, VA; Schwarz, EI; Stöberl, AS; Stradling, JR; Turnbull, CD, 2017) |
| "Obstructive sleep apnea is characterized by intermittent hypoxia and hypercapnia." | ( Eskandari, D; Grote, L; Hedner, J; Penzel, T; Schneider, H; Zou, D, 2017) |
| "Obstructive sleep apnea is associated with increased complication rates postoperatively." | ( Desai, NA; Jules-Elysée, KM; Liguori, GA; Luu, TH; Ma, Y; Memtsoudis, SG; Zhang, W, 2018) |
| "Obstructive sleep apnea is highly prevalent and requires consideration of opioid sparing techniques and careful postoperative disposition." | ( Chidambaran, V; Mahmoud, M; Tewari, A, 2018) |
| "Obstructive sleep apnea is common in the early postpartum period and often persisted at least 6 months." | ( Aschenbrenner, CA; Eisenach, JC; Houle, TT; Pinyan, CW; Street, LM, 2018) |
| "Obstructive sleep apnea is the most prevalent type of obesity-related sleep disorder that lead to an increased risk for numerous chronic health conditions." | ( Annunziata, G; Barrea, L; Colao, A; Di Somma, C; Laudisio, D; Muscogiuri, G; Savastano, S, 2019) |
| "Obstructive sleep apnea is associated with an increased risk of developing mild cognitive impairment and dementia." | ( Cross, N; D'Rozario, A; Duffy, SL; Grunstein, R; Hoyos, C; Lagopoulos, J; McKinnon, AC; Naismith, SL; Osorio, RS; Shine, JM; Terpening, Z, 2020) |
| "Obstructive sleep apnea is characterized by chronic intermittent hypoxia (CIH), which is a risk factor for renal peritubular capillary (PTC) loss, and angiotensin II receptor blockers can alleviate PTC loss." | ( Chu, Y; Jiang, Z; Wu, J; Yu, Q, 2020) |
| "Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy." | ( Lundy, SD; Parekh, NV; Shoskes, DA, 2020) |
| "Obstructive sleep apnea is associated with a two-fold likelihood of being prescribed opioids for pain." | ( Athar, W; Bastian, LA; Chen, K; DeRycke, EC; Fiellin, DA; Haskell, S; Yaggi, HK, 2020) |
| "Obstructive Sleep Apnea is emerging as a global health epidemic, particularly due to the obesity pandemic." | ( Groneberg, DA; Klingelhöfer, D; Seeger-Zybok, RK, 2020) |
| "Obstructive sleep apnea is a risk factor for respiratory depression following opioid administration as well as opioid-induced hyperalgesia." | ( Adler, AC; Chandrakantan, A; Nathanson, BH; von Ungern-Sternberg, BS, 2021) |
| "Obstructive sleep apnea is associated with low TT and FT levels in severely obese men." | ( Arizanović, Z; Ivović, M; Kendereški, A; Marina, LV; Soldatović, I; Stojanović, M; Tančić-Gajić, M; Vujović, S; Vukčević, M; Đogo, A, 2021) |
| "Obstructive sleep apnea is inversely associated with male serum testosterone levels, independent of body mass index and age." | ( Cao, Y; Jiao, YZ; Meng, YH; Qu, H; Su, L; Zhang, SZ; Zhu, J, 2022) |
| "Obstructive sleep apnea is a common cause of AF, and treating it effectively reduces AF episodes." | ( Gupta, S; Lavie, CJ; O'Keefe, EL; O'Keefe, JH; Sturgess, JE, 2021) |
| "Obstructive sleep apnea syndrome is associated with urological symptoms, including overactive bladder (OAB)." | ( Aslan, R; Demir, M; Ertaş, K; Eryılmaz, R; Kırmızıtoprak, Ş; Taken, K; Yıldız, H, 2022) |
| "The prevalence of obstructive sleep apnea is higher in women after menopause." | ( Benediktsdottir, B; Dadvand, P; Demoly, P; Franklin, KA; Gislason, T; Heinrich, J; Holm, M; Hustad, S; Jõgi, R; Leynaert, B; Lindberg, E; Martinez-Moratalla, J; Pereira-Vega, A; Pesce, G; Pin, I; Raherison, C; Real, FG; Sainz De Aja, L; Sigurðardóttir, ES; Triebner, K; van der Plaat, DA, 2022) |
| "Obstructive sleep apnea is a chronic, sleep-related breathing disorder, which is an independent risk factor for cardiovascular disease." | ( Chai, CS; Goh, SL; Lim, LL; Lim, QH; Loh, HH; Sukor, N; Yee, A, 2023) |
| "Obstructive sleep apnea is associated with lower testosterone, even after controlling for age and obesity whereas the conclusion that continuous positive airway pressure therapy has no effect on testosterone is premature because available studies are underpowered and better-quality studies suggest otherwise." | ( Liu, PY; Reddy, RT, 2022) |
| "Obstructive sleep apnea is a prevalent and poorly treated cardiovascular disease that leads to hypertension and autonomic imbalance." | ( Alber, BR; Cheung, EC; Dyavanapalli, J; Escobar, JB; Gill, A; Harral, G; Jain, V; Kay, MW; Kowalik, G; Melkie, M; Mendelowitz, D; Rodriguez, J; Russo, R; Schunke, KJ, 2023) |
| "Obstructive sleep apnea syndrome is one of these sleep disorders and is associated with the severity of motor symptoms in Parkinson's disease." | ( Kim, H; Kim, JS; Lyoo, CH; Oh, YS, 2023) |
| "The treatment of obstructive sleep apnea is often impeded by intolerance of positive airway pressure therapy, which is frequently attributed to the inability to breathe through the nose." | ( Ali, MM; Ellison, M; Iweala, OI; Spector, AR, 2023) |
| Excerpt | Reference |
|---|
| "This finding opens new avenues for the treatment of obstructive sleep apnea syndrome, and provides a foundation to explore the neural and pharmacological control of respiration-related motoneurons during rapid eye movement sleep." | ( Chase, MH; Fung, SJ; Morales, FR; Xi, M; Yamuy, J, 1999) |
| "We studied 23 patients with obstructive sleep apnea syndrome diagnosed by polysomnography who were treated with nasal CPAP." | ( Chin, K; Mishima, M; Miyasaka, M; Nakamura, T; Ohi, M; Shimizu, K, 2000) |
| "Therefore, bilirubin levels in OSAHS patients were analyzed before and after nasal continuous positive airway pressure (nCPAP) therapy." | ( Chin, K; Mishima, M; Miyaoka, F; Nakamura, T; Ohi, M; Shimizu, K, 2001) |
| "The subjects were 22 patients with OSAHS (mean (SEM) apnea and hypopnea index of 60 (5)) who were treated with nCPAP and 13 controls." | ( Chin, K; Mishima, M; Miyaoka, F; Nakamura, T; Ohi, M; Shimizu, K, 2001) |
| "To investigate whether in patients with obstructive sleep apnea syndrome (OSAS) the systemic immunity is disturbed and whether it changes with nasal continuous positive airway pressure (NCPAP) therapy." | ( Chin, K; Kita, H; Mishima, M; Nakamura, T; Ohi, M; Shimizu, K, 2001) |
| "Patients with obstructive sleep apnea/hypopnea syndrome can experience residual daytime sleepiness despite regular use of nasal continuous positive airway pressure therapy." | ( Black, JE; Matheson, JK; Pack, AI; Schwartz, JR, 2001) |
| "Evidence suggests that untreated obstructive sleep apnea (OSA) can lead to hypertension, cardiovascular disease, and stroke." | ( Berger, HA; Dyken, ME; Yamada, T, 2003) |
| "To investigate obstructive sleep apnea (OSA) in a consecutively encountered, nonselected population of young patients with Down syndrome using standard overnight polysomnography and to determine the effects of therapy." | ( Dyken, ME; Lin-Dyken, DC; Poulton, S; Sedars, E; Zimmerman, MB, 2003) |
| "We investigated whether obstructive sleep apnea itself is an independent risk factor for increased insulin resistance and whether continuous positive airway pressure (CPAP) treatment improves insulin sensitivity." | ( Ficker, JH; Fuchs, FS; Hahn, EG; Harsch, IA; Jahreiss, H; Konturek, PC; Lohmann, T; Radespiel-Tröger, M; Schahin, SP; Weintz, O; Wiest, GH, 2004) |
| "Some patients with obstructive sleep apnea/hypopnea syndrome (OSA/HS) who are regular users of nasal continuous positive airway pressure (nCPAP) therapy continue to experience daytime sleepiness that impairs performance and quality of life." | ( Dinges, DF; Weaver, TE, 2003) |
| "Effective treatment of obstructive sleep apnea with nasal continuous positive airway pressure has been associated with improved insulin sensitivity and testicular function in individuals with obstructive sleep apnea." | ( Grunstein, R; Liu, P; Phillips, C; Yee, B, 2004) |
| "Thus, investigating whether obstructive sleep apnea itself is an independent risk factor for increased insulin resistance and whether continuous positive airway pressure treatment (CPAP) might improve insulin sensitivity brings up considerable methodological problems." | ( Hahn, EG; Harsch, IA; Konturek, PC, 2005) |
| "Sixty-one patients with OSAHS diagnosed by polysomnography were treated with uvulopalatopharyngoplasty." | ( Cao, H; Liu, LW; Luo, H; Wang, PJ; Xiao, H; Yu, Y, 2005) |
| "A surgical protocol in the treatment of obstructive sleep apnea syndrome (OSAS) is presented." | ( Ferri, J; Smatt, Y, 2005) |
| "Twenty three cases diagnosed as OSAHS by polysomnography (PSG) were treated as trial group, 12 cases excluded from OSAHS by PSG were taken as control group,and 15 patients of the trial group were treated by UPPP and were taken as before UPPP therapy group and after UPPP therapy group." | ( Du, X; Luan, X; Pu, H; Shu, C, 2005) |
| "Fifty-four cases with OSAHS treated with UPPP in our department were analyzed retrospectively." | ( Cai, Q; Chen, H; Chen, Q; Ye, H; Zhang, Z; Zhen, Y, 2006) |
| "To serious OSAHS, we should treat them individually." | ( Cai, Q; Chen, H; Chen, Q; Ye, H; Zhang, Z; Zhen, Y, 2006) |
| "Some patients with obstructive sleep apnea/hypopnea syndrome (OSA/HS) experience excessive sleepiness (ES) that might not resolve with nasal continuous positive airway pressure (nCPAP) treatment." | ( Arora, S; Black, J; Niebler, G; Roth, T; Schmidt-Nowara, W; Wesnes, KA; White, D, 2006) |
| "A significant number of patients with obstructive sleep apnea neither tolerate positive airway pressure (PAP) therapy nor achieve successful outcomes from either upper airway surgeries or use of an oral appliance." | ( Ballard, RD; Guilleminault, C; Magalang, UJ; Sanders, MH; Strohl, KP; Veasey, SC, 2006) |
| "16 patients with severe obstructive sleep apnea (apnea+ hypopnea index > 30/hr), on CPAP therapy for at least 6 months." | ( Berry, RB; Patel, PB, 2006) |
| "In cases of obstructive sleep apnea syndrome (OSAS) with intolerance of n-CPAP (nasal continuous positive airway pressure) treatment, hyoidthyroidpexia (synonym: hyoid suspension) has recently been advocated by some authors as a valuable surgical option." | ( Bauknecht, HC; Fitze, I; Hölzl, M; Reinhardt, A; Scherer, H; Seidner, W, 2006) |
| "Severe OSAHS patients should be underwent synthesized treatment." | ( Guo, X; Hui, L; Sun, Z; Wang, Y, 2007) |
| "Patients with obstructive sleep apnea treated with nasal continuous positive airway pressure (CPAP) often complain of nasal side effects." | ( Dawson, A; Fahrenholz, J; Jalowayski, AA; Kline, LE; Shadan, FF, 2005) |
| "To study the treatment of OSAHS with nasal diseases by nasal operation." | ( Hu, H, 2007) |
| "We hypothesised that OSAHS combined with severe nocturnal hypoxaemia causes impaired vascular function that can be reversed by continuous positive airways pressure (CPAP) therapy." | ( Al-Abri, M; Cross, MD; Douglas, NJ; Mackay, TW; Mills, NL; Newby, DE; Riha, R; Vennelle, M, 2008) |
| "Patients with OSAHS and frequent nocturnal desaturations have impaired endothelial dependent and endothelial independent vasodilatation that is proportional to hypoxaemia and is improved by CPAP therapy." | ( Al-Abri, M; Cross, MD; Douglas, NJ; Mackay, TW; Mills, NL; Newby, DE; Riha, R; Vennelle, M, 2008) |
| "Habitual snoring and obstructive sleep apnea have been associated with bed-wetting in children, and effective obstructive sleep apnea treatment may improve enuresis." | ( Crabtree, VM; Gozal, D; Kheirandish-Gozal, L; Sans Capdevila, O, 2008) |
| "Fifty-nine patients with OSAHS were treated through uvulopalatopharyngoplasty." | ( Guo, X; Ning, B; Xu, L, 2008) |
| "Thirty cases with OSAHS were treated with acupuncture at Shanglianquan (Extra), Fengfu (GV 16), Yamen (GV 15), Fengchi (GB 20), etc." | ( Liang, RL; Liu, Z; Niu, YX; Piao, XM; Wu, LZ; Xu, J, 2009) |
| "Rule B detected OSAHS and correlated well with response to treatment, but many more were categorized as mild (5 < AHI < 15) at baseline." | ( Guilleminault, C; Hagen, CC; Huynh, NT, 2009) |
| "Patients had severe obstructive sleep apnea treated at a specialized sleep center with frequent follow-up; results may not be generalizable to different settings." | ( Chang, AS; Holley, AB; Kelly, WF; Lettieri, CJ; Roop, SA; Shah, AA, 2009) |
| "One hundred ninety two patients with OSAHS diagnosed by polysomnography were treated through uvulopalatopharyngoplasty (UPPP)." | ( Guo, X; Li, GD; Li, XT; Wang, Y; Xu, LX; Yang, HA, 2009) |
| "Our objectives were to: (1) characterize obstructive sleep apnea (OSA) and CSA in patients in methadone maintenance treatment (MMT) for opioid dependence; (2) examine factors associated with SDB in this population; and (3) investigate whether SDB was related to severity of subjective sleep complaints in MMT patients with subjective sleep disturbances." | ( Anderson, BJ; Corso, RP; Kurth, ME; Millman, RP; Sharkey, KM; Stein, MD, 2010) |
| "Subjects with obstructive sleep apnea unable to tolerate positive airway pressure therapy." | ( Goldberg, AN; Kezirian, EJ; Ma, W; Malhotra, A; McCulloch, CE; White, DP, 2010) |
| "Pharmacological treatment of obstructive sleep apnea with a combination of pseudoephedrine and domperidone." | ( Gooley, TA; Kapur, VK; Larrain, A; Pope, CE, 2010) |
| "To evaluate the impact of multilevel obstructive sleep apnea surgical treatment on sleep-disordered breathing severity, health-related measures, and quality of life, and to examine the association between changes in sleep-disordered breathing severity and these other outcomes." | ( Goldberg, AN; Kezirian, EJ; Malhotra, A; White, DP, 2010) |
| "Subjects with obstructive sleep apnea unable to tolerate positive airway pressure therapy and with evidence of multilevel (palate and hypopharynx) obstruction underwent uvulopalatopharyngoplasty, tonsillectomy, and genioglossus advancement, with or without hyoid suspension." | ( Goldberg, AN; Kezirian, EJ; Malhotra, A; White, DP, 2010) |
| "Ten patients with moderate and severe OSAHS were treated with nCPAP." | ( Chen, L; Li, M; Li, N; Li, QY; Liu, JL; Ma, GH; Wan, HY; Yang, K; Ye, L, 2010) |
| "Pediatric obstructive sleep apnea refractory to adenotonsillectomy that is due to retroglossal and base-of-tongue collapse remains difficult to treat." | ( Shott, SR; Wootten, CT, 2010) |
| "Treatment of obstructive sleep apnea (OSA) by continuous positive airway pressure (CPAP) usually causes a reduction in blood pressure (BP), but several factors may interfere with its effects." | ( Bonanno, A; Bonsignore, MR; Bue, AL; Insalaco, G; Marrone, O; Riccobono, L; Salvaggio, A, 2011) |
| "The surgical evaluation of obstructive sleep apnea is designed to characterize the pattern of upper airway obstruction in order to develop an effective treatment plan for an individual patient." | ( de Vries, N; Hohenhorst, W; Kezirian, EJ, 2011) |
| "Many patients with obstructive sleep apnea syndrome (OSA) are unable or unwilling to use continuous positive airway pressure (CPAP) therapy when traveling to the mountains for work or recreation even though they risk pronounced hypoxemia and exacerbation of sleep apnea." | ( Bloch, KE; Kohler, M; Latshang, TD; Nussbaumer-Ochsner, Y; Thurnheer, R; Ulrich, S, 2012) |
| "This study included patients with obstructive sleep apnea (OSA) and primary snoring who wish or require an alternative therapy to the gold standard, continuous positive airway pressure (CPAP)." | ( Eichler, C; Hörmann, K; Maurer, JT; Sommer, JU; Stuck, BA, 2013) |
| "Donepezil treatment improved obstructive sleep apnea index, oxygen saturation, and sleepiness in parallel with a reduction in sleep efficiency." | ( Guilleminault, C; Moraes, W; Poyares, D; Sukys-Claudino, L; Tufik, S, 2012) |
| "To illustrate that the diagnosis of obstructive sleep apnea (OSA) is dependent on the polysomnographic scoring criteria used, and the success rates of treatments for OSA are dependent on the defined outcome measures." | ( Antic, NA; Carney, AS; Hobson, JC; Mackay, S; McEvoy, RD; Robinson, S; Windler, S, 2012) |
| "In patients with obstructive sleep apnea (OSA) syndrome and chronic respiratory insufficiency one of the options of treatment is bilevel positive airway pressure (BPAP) during sleep." | ( Brzecka, A; Jankowska, R; Kosacka, M; Piesiak, P, 2013) |
| "Patients with obstructive sleep apnea (AHI ≥ 30 /h) had H2O2 analysis of EBC after native PSG, after the first night and after 6 weeks of CPAP therapy." | ( Litterst, P; Westhoff, M, 2012) |
| "Among patients with obstructive sleep apnea, treatment under a primary care model compared with a specialist model did not result in worse sleepiness scores, suggesting that the 2 treatment modes may be comparable." | ( Antic, NA; Catcheside, PG; Chai-Coetzer, CL; Dunn, S; Eckermann, S; Esterman, A; McEvoy, RD; Reed, RL; Rowland, LS; Vowles, N; Williams, H, 2013) |
| "To determine how the obstructive sleep apnea (OSA) patient's pathophysiological traits predict the success of the treatment aimed at stabilization or increase in respiratory motor outputs, we studied 26 newly diagnosed OSA patients [apnea-hypopnea index (AHI) 42 ± 5 events/h with 92% of apneas obstructive] who were treated with O2 supplementation, an isocapnic rebreathing system in which CO2 was added only during hyperpnea to prevent transient hypocapnia, and a continuous rebreathing system." | ( Dempsey, JA; Fedie, JE; Gong, Y; Pegelow, DF; Teodorescu, M; Teodorescu, MC; Xie, A, 2013) |
| "Drug treatment for obstructive sleep apnea (OSA) is desirable because at least 30% of patients do not tolerate continuous positive airway pressure (CPAP) treatment." | ( Ruetten, H; Steinmeyer, K; Wirth, KJ, 2013) |
| "Sixty seven patients with OSAHS, 20 healthy controls with matched age, BMI, and education, 15 patients with OSAHS after effective treatment of continuous positive airway pressure (CPAP) with matched age, BMI, and education were enrolled." | ( Liu, HG; Liu, X; Shang, J; Xu, YJ; Yang, XH, 2013) |
| "The serum SOD level in patients with OSAHS was decreased compared to that in healthy controls [(89 ± 8) vs (57 ± 9) U/ml], but it was increased after effective CPAP treatment." | ( Liu, HG; Liu, X; Shang, J; Xu, YJ; Yang, XH, 2013) |
| "Excluding moderate to severe obstructive sleep apnea patients DISE is an indispensable tool in treatment decision in all SDB patients." | ( De Medts, J; Delsupehe, KG; Pilaete, K, 2014) |
| "Studies of adult patients with OSAHS who reported HCY levels pre- and post-CPAP treatment were collected by two independent reviewers." | ( Chen, X; Dong, J; Kong, W; Lu, M; Niu, X; Xiao, Y; Zhang, R, 2014) |
| "Treatment of pediatric obstructive sleep apnea syndrome is surgical." | ( Benedek, P; Csábi, E; Katona, G; Kiss, G, 2014) |
| "Patients with severe obstructive sleep apnea syndrome should be treated in hospital where pediatric intensive care unit is available." | ( Benedek, P; Csábi, E; Katona, G; Kiss, G, 2014) |
| "We primarily developed an OSAHS and MAD therapy animal model with narrow oropharynx in upper airway which could be further available for OSAHS analysis." | ( Dong, F; Liu, CY; Liu, Y; Lu, HY; Wang, J; Xiao, W, 2015) |
| "MAD therapy for OSAHS could prevent genioglossus fatigue and abnormal fibre-type distribution of genioglossus in OSAHS." | ( Dong, FS; Hu, XY; Liu, CY; Lu, HY; Ma, WS; Wang, J; Wang, W, 2015) |
| "The treatment method of children with OSAHS should be selected according to the age, condition of disease, and size of the adenoid and tonsil." | ( Lin, Z; Shen, L; Xu, Y; Yang, Z, 2014) |
| "A total of 80 CAD patients with OSAHS were randomly assigned to receive conventional treatment (control, n = 40) and additional allitridi treatment (120 mg/day, n = 40) for 6 months." | ( Li, X; Nie, X; Shang, M; Su, L; Wei, Y; Zhou, Y, 2014) |
| "In acute ascent to altitude, untreated obstructive sleep apnea (OSA) is often replaced with central sleep apnea (CSA)." | ( Bell, JE; Brown, SM; Cloward, TV; Grissom, CK; Lanspa, MJ; Nishida, K; Weaver, LK, 2015) |
| "Acute altitude exposure in patients with obstructive sleep apnea treated with positive airway pressure is associated with hypoxemia, decreased sleep time, and increased frequency of hypopneas compared with baseline altitude." | ( Bell, JE; Brown, SM; Cloward, TV; Grissom, CK; Lanspa, MJ; Nishida, K; Weaver, LK, 2015) |
| "Data on the impact of obstructive sleep apnea syndrome (OSAS) and its treatment on resting energy expenditure (REE) are currently few and conflicting." | ( Argyropoulou, P; Athanasiou, I; Boutou, AK; Chavouzis, N; Fekete, K; Ilonidis, G; Kioumis, I; Kontakiotis, T; Pataka, A; Pitsiou, G, 2016) |
| "20 female patients with obstructive sleep apnea (OSA) established on long-term CPAP treatment." | ( Armitstead, J; Baker, V; Bateman, P; Eastwood, P; Hillman, D; Ketheeswaran, S; King, S; McArdle, N; Ramanan, D; Richards, G; Shepherd, K; Wimms, A, 2015) |
| "Twenty-four patients with severe OSAHS from January 2011 to January 2014 treated by three different methods of maxillomandibular advancement (MMA) and genioplasty, maxillomandibular advancement without rotation plus genioplasty, maxillomandibular advancement with counterclockwise rotation plus advancement genioplasty, maxillomandibular advancement with first premolars extraction and subapical osteotomy setback under general anesthesia were included in the study." | ( Ding, M; Koirala, U; Ma, Q; Shi, J; Wang, W; Yu, B, 2015) |
| "To evaluate the association of obstructive sleep apnea hypopnea syndrome (OSAHS) with carotid atherosclerosis and the efficacy of continuous positive airway pressure (CPAP) treatment." | ( Bian, H; Chen, B; Chen, Y; He, J; Hu, C; Ji, L; Zhang, W; Zhu, S, 2015) |
| "Thirty patients with untreated obstructive sleep apnea and 20 healthy age- and education-matched controls performed the Iowa Gambling Task, a decision-making task under initial ambiguity, as well as an extensive neuropsychological test battery." | ( Delazer, M; Frauscher, B; Heidbreder, A; Högl, B; Mitterling, T; Stefani, A; Zamarian, L, 2016) |
| "The thioredoxin values, in untreated OSAHS patients, appear to be reduced than in OSAHS patients treated (p<0." | ( Campione, G; Cocuzza, S; Di Luca, M; Di Mauro, P; Licciardello, L; Maiolino, L; Serra, A, 2016) |
| "In the treatment of obstructive sleep apnea (OSA) with an oral appliance (OA), there is no gold standard method to fine-tune the mandibular advancement." | ( Alkhraisat, MH; Almeida, GZ; Anitua, E; Durán-Cantolla, J, 2017) |
| "Untreated obstructive sleep apnea (OSA) is a risk factor for hypertension and cardiac events, and is associated with increased mortality." | ( Ramakrishnan, N; Ramalingam, IP; Viswanathan, V, 2017) |
| "The diagnosis and effective treatment of obstructive sleep apnea (OSA) in adults is an urgent health priority." | ( Aurora, RN; Carden, KA; Chervin, RD; Kirsch, DB; Kristo, DA; Malhotra, RK; Martin, JL; Olson, EJ; Ramar, K; Rosen, CL; Rosen, IM; Rowley, JA, 2018) |
| "The Hcy and GSH concentrations of OSAHS patients with CPAP treatment showed no apparent change compared with the prior treatment, but the MDA level was obviously lower after CPAP treatment." | ( Fang, Q; Jiang, M; Li, J; Wang, L; Yu, LQ, 2018) |
| "There is a high prevalence of obstructive sleep apnea (OSA) in patients with Pierre Robin sequence (PRS), and treatment approaches are highly variable." | ( Chin, K; French, B; Kian, A; Randall, RS, 2018) |
| "Patients with obstructive sleep apnea (OSA) requiring continuous positive airway pressure (CPAP) therapy undergoing skull base surgery represent a challenging group." | ( Algird, A; Choi, DL; Reddy, K; Rotenberg, BW; Sommer, DD; Vescan, A; Weitzel, EK, 2019) |
| "Children (8 to 14 yr) with or without obstructive sleep apnea were administered a 15-min, fixed-rate remifentanil infusion (0." | ( Juriga, L; Kharasch, ED; Montana, MC; Sharma, A, 2019) |
| "Approximately 60% of obstructive sleep apnea (OSA) diagnoses are position-dependent, and avoidance of the supine position could represent an effective treatment." | ( Barbé, F; Cordero-Guevara, J; Durán-Cantolla, J; Durán-Carro, J; Hidalgo Armas, L; Manjón, JL; Turino, C; Vaca, R, 2019) |
| "Oronasal breathing may adversely impact obstructive sleep apnea (OSA) patients either by increasing upper airway collapsibility or by influencing continuous positive airway pressure (CPAP) treatment outcomes." | ( Barroso, LP; Carvalho, TS; Fernandes, PHS; Genta, PR; Lorenzi-Filho, G; Madeiro, F; Moriya, HT; Nakagawa, NK; Nascimento, JA, 2019) |
| "Many patients with obstructive sleep apnea (OSA), but not all, have a reduction in blood pressure (BP) with positive airway pressure (PAP) treatment." | ( Arnardóttir, ES; Benediktsdóttir, B; Chirinos, JA; Gislason, T; Gudmundsdóttir, S; Guo, X; Keenan, BT; Kuna, ST; Maislin, D; Maislin, G; Pack, AI; Pack, FM; Schwab, RJ; Sifferman, A; Staley, B; Townsend, RR, 2019) |
| "The efficacy of obstructive sleep apnea (OSA) therapy with continuous positive airway pressure (CPAP) on uric acid (UA) yielded conflicting results." | ( Chen, L; Chen, M; Chen, Q; Huang, J; Huang, Y; Li, P; Lin, G; Lin, Q, 2019) |
| "Eighteen OSAHS patients with T2DM, who were treated with dapagliflozin and metformin, were assigned as the dapagliflozin group." | ( Bai, XY; Sun, Q; Tang, Y; Zhang, M; Zhou, QL; Zhou, YF, 2019) |
| "We evaluated the effect of OSAHS treatment with MADs on the myocardium." | ( Kang, W; Liu, C; Lu, H; Qiao, X; Yang, X; Zhang, S; Zhou, Z, 2020) |
| "CPAP is the most common treatment for obstructive sleep apnea." | ( Almeida, AB; Kleymann, J; Kolditz, M; Koschel, D; Langner, S; Schweigert, M; Tausche, K, 2020) |
| "The patient was diagnosed with severe obstructive sleep apnea (OSA), and administration of a polysomnography test revealed an apnea-hypopnea index (AHI) of 30." | ( Jang, JW; Jeon, SY; Kang, SY; Kim, SW; Kwon, OE; Min, JY, 2021) |
| "Search terms included "obstructive sleep apnea" and "testosterone replacement therapy." | ( Hotaling, JM; Lipshultz, LI; Pastuszak, AW; Payne, K, 2021) |
| "Many adults with obstructive sleep apnea (OSA) use device treatments inadequately and remain untreated." | ( Carney, AS; Catcheside, PG; Chai-Coetzer, CL; Chia, M; Cistulli, PA; Hodge, JC; Jones, A; Kaambwa, B; Lewis, R; MacKay, S; McArdle, N; McEvoy, RD; Ooi, EH; Pinczel, AJ; Rees, G; Singh, B; Stow, N; Weaver, EM; Woodman, RJ; Woods, CM; Yeo, A, 2020) |
| "Subjects with both OSAHS and glucose dysregulation received CPAP treatment and underwent an oral glucose tolerance test." | ( Chang, SC; Gong, LJ; Li, SQ; Liu, ZL; Wu, QH; Wu, X, 2021) |
| "Improving sleep quality in patients with obstructive sleep apnea (OSA) by positive airway pressure therapy is associated with a decrease of blood pressure (BP)." | ( Babel, N; Bertram, S; Büchner, N; Doevelaar, A; Mühlberger, D; Racovitan, D; Rohn, B; Seibert, FS; Seidel, M; Toma, D; Wang, S; Westhoff, TH, 2022) |
| "In addition, compared to the number of OSAHS in model group, the number of OSAHS in control group, sham operation group and treatment group is obviously decreased." | ( Chen, Y; Liang, Y; Song, K; Tian, T; Zhu, S, 2022) |
| "Despite the high prevalence of obstructive sleep apnea (OSA) and concurrent use of opioid therapy, no large-scale population studies have investigated whether opioid use and pre-existing OSA may interact synergistically to increase the risk of adverse health consequences." | ( Aaron, SD; Ahmed, T; Bryson, GL; Chung, F; Gershon, AS; Godbout, M; Gomes, T; Kendzerska, T; Malhotra, A; McIsaac, DI; Povitz, M; Talarico, R; Tanuseputro, P, 2022) |
| "A 62-year-old man with untreated obstructive sleep apnea syndrome (OSAS) was admitted to our hospital complaining of abdominal stiffness." | ( Aono, D; Karashima, S; Kometani, M; Ohmori, A; Sawamura, T; Takeda, Y; Yoneda, T, 2023) |
| "A 62-year-old man with untreated obstructive sleep apnea syndrome (OSAS) was admitted to our hospital complaining of abdominal stiffness." | ( Aono, D; Karashima, S; Kometani, M; Ohmori, A; Sawamura, T; Takeda, Y; Yoneda, T, 2023) |
| "The pathophysiology of obstructive sleep apnea in pregnancy remains poorly understood and studies examining the effect of treatment with positive airway pressure on pregnancy have been limited." | ( Cashmere, JD; Facco, FL; Gallaher, M; Hubel, C; Patel, SR; Wisniewski, S; Wolsk, J, 2023) |
| "Pharmacotherapy for obstructive sleep apnea (OSA) regained consideration after the discovery that atomoxetine and oxybutynin greatly reduced OSA severity." | ( Corser, B; Eves, E; Rucosky, G; Warren-McCormick, J, 2023) |
| "The treatment of obstructive sleep apnea is often impeded by intolerance of positive airway pressure therapy, which is frequently attributed to the inability to breathe through the nose." | ( Ali, MM; Ellison, M; Iweala, OI; Spector, AR, 2023) |
| "Untreated obstructive sleep apnea (OSA) is prevalent among veterans with PTSD and has been shown to interfere with other PTSD treatments." | ( Bismark, A; Colvonen, P; Hunt, C; Lee, E; Nokes, B; Park, J; Ramanathan, D; Titone, MK, 2023) |
| "The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: a retrospective clinical study." | ( Bismark, A; Colvonen, P; Hunt, C; Lee, E; Nokes, B; Park, J; Ramanathan, D; Titone, MK, 2023) |
| "We sought to determine if risk for obstructive sleep apnea (OSA), a history of OSA, and/or treatment of OSA has a different association with incident cognitive impairment or cognitive decline in Black individuals and White individuals." | ( Aziz, Y; Bennett, A; Blair, J; Demel, SL; Foster, F; Hill, EJ; Hoffmann, CM; Hooper, D; Howard, VJ; Hyacinth, HI; Johnson, J; Karkoska, K; Manly, JJ; Molano, J; Petrov, ME; Pounders, J; Sawyer, RP; Shatz, R; Timmerman, E; Yu, F, 2023) |